SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-25
👔
INTEGRATED BIOPHARMA INC
@INBP_InsiderForm 4 Filing: Friedman Eric J Acquires (Grant) shares of $INBP
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
INTEGRATED BIOPHARMA INC
Ticker: $INBP
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-06-24
Shares: 50,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Friedman Eric J, holds the title of Director at INTEGRATED BIOPHARMA INC.
On 2026-06-24, the insider transacted 50,000 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Friedman Eric J (Director) was granted $0 of $INBP
Post-Transaction Position: 50 shares
SEC Accession No: 0001216280-26-000001 (CIK: 1216280)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.